Many NK cell receptor ligands are up-regulated on the surface of cancer cells in response to cellular stresses, damage or other stimuli [98], which stimulate anti-tumor immunity when detected by NK cell surface receptors, such as NKG2D and NKp46 [98,105]. The gene discussed is NCR1; the disease is neoplasm.